[HTML][HTML] Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment

A Koch, H Cox, V Mizrahi - Current Opinion in pharmacology, 2018 - Elsevier
Highlights•Management of tuberculosis is complicated by high levels of drug resistance in
some regions of the world.•Increasingly, molecular diagnostics are being used for resistance …

Tuberculosis: an overview of the immunogenic response, disease progression, and medicinal chemistry efforts in the last decade toward the development of potential …

A Sharma, M De Rosa, N Singla, G Singh… - Journal of medicinal …, 2021 - ACS Publications
Tuberculosis (TB) is a slow growing, potentially debilitating disease that has plagued
humanity for centuries and has claimed numerous lives across the globe. Concerted efforts …

Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review

D Kiran, BK Podell, M Chambers… - Seminars in …, 2016 - Springer
Infection by the intracellular bacterial pathogen Mycobacterium tuberculosis (Mtb) is a major
cause of morbidity and mortality worldwide. Slow progress has been made in lessening the …

Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota

JJ Goedert, X Hua, A Bielecka, I Okayasu… - British journal of …, 2018 - nature.com
Background: The diversity and composition of the gut microbiota may affect breast cancer
risk by modulating systemic levels of oestrogens and inflammation. The current investigation …

Intracellular Mycobacterium tuberculosis exploits multiple host nitrogen sources during growth in human macrophages

K Borah, M Beyß, A Theorell, H Wu, P Basu… - Cell reports, 2019 - cell.com
Nitrogen metabolism of Mycobacterium tuberculosis (Mtb) is crucial for the survival of this
important pathogen in its primary human host cell, the macrophage, but little is known about …

Derailing the aspartate pathway of Mycobacterium tuberculosis to eradicate persistent infection

EJ Hasenoehrl, D Rae Sajorda, L Berney-Meyer… - Nature …, 2019 - nature.com
A major constraint for developing new anti-tuberculosis drugs is the limited number of
validated targets that allow eradication of persistent infections. Here, we uncover a …

Metabolic anticipation in Mycobacterium tuberculosis

H Eoh, Z Wang, E Layre, P Rath, R Morris… - Nature …, 2017 - nature.com
Humans serve as both host and reservoir for Mycobacterium tuberculosis, making
tuberculosis a theoretically eradicable disease. How M. tuberculosis alternates between …

Tuberculous granuloma: emerging insights from proteomics and metabolomics

AR Sholeye, AA Williams, DT Loots… - Frontiers in …, 2022 - frontiersin.org
Mycobacterium tuberculosis infection, which claims hundreds of thousands of lives each
year, is typically characterized by the formation of tuberculous granulomas—the …

Metabolômica: definições, estado-da-arte e aplicações representativas

GAB Canuto, JL Costa, PLR Cruz, ARL Souza… - Química …, 2018 - SciELO Brasil
Metabolomics is an emerging and promising omics approach used to understand biological
mechanisms. By untargeted and targeted metabolomics analyses, metabolites are …

S-Adenosylmethionine–responsive cystathionine β-synthase modulates sulfur metabolism and redox balance in Mycobacterium tuberculosis

P Bandyopadhyay, I Pramanick, R Biswas, S Ps… - Science …, 2022 - science.org
Methionine and cysteine metabolisms are important for the survival and pathogenesis of
Mycobacterium tuberculosis (Mtb). The transsulfuration pathway converts methionine to …